Evidence map›Paper›PMID 20080691›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Protein phosphatase PHLPP1 controls the light-induced resetting of the circadian clock.

Satoru Masubuchi, Tianyan Gao, Audrey O'Neill, Kristin Eckel-Mahan, Alexandra C Newton, Paolo Sassone-Corsi

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 55 citations in OpenAlex.

  1. PHLPP is neither a Phosphatase nor a Tumor Suppressor.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Circadian Clock Desynchronization and Insulin Resistance.International journal of environmental research and public health · 2022
    Review
  9. Article
  10. PHLPP Signaling in Immune Cells.Current topics in microbiology and immunology · 2022
    Review
  11. Myeloid Lineage Ablation ofInternational journal of molecular sciences · 2021
    Article
  12. Article
  13. Pleckstrin homology (PH) domain and Leucine Rich Repeat Phosphatase 1 (Phlpp1) Suppresses Parathyroid Hormone Receptor 1 (Pth1r) Expression and Signaling During Bone Growth.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Satoru MasubuchiDepartment of Pharmacology, School of Medicine, University of California, Irvine, CA 92697, USA.
Tianyan Gao
Audrey O'Neill
Kristin Eckel-Mahan
Alexandra C Newton
Paolo Sassone-Corsi
University of California, Irvine · USUniversity of California, San Diego · US

Funding

GRADUATE TRAINING IN CELLULAR &MOLECULAR PHARMACOLOGYT32GM007752 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, HANDEL, TRACY M · 1985 to 2023
$13.5M
Signal Termination by PHLPP, PH domain Leucine-rich repeat Protein PhosphataseR01GM067946 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NEWTON, ALEXANDRA C. · 2003 to 2014
$4.1M
Chromatin Remodeling and Circadian Clock ControlR01GM081634 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI SASSONE-CORSI, PAOLO · 2007 to 2011
$1.6M
Translational Research in Cancer Genomic MedicineT32CA113265 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI LEE, WEN-HWA · 2007 to 2011
$1.4M
Epigenetics and Circadian Clock: deciphering the physiological and molecular pathR21AG033888 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI SASSONE-CORSI, PAOLO · 2009 to 2010
$343k
NCI NIH HHS CA 113265NCI NIH HHS T32 CA113265NIA NIH HHS R21 AG033888NIGMS NIH HHS GM 67946NIGMS NIH HHS R01 GM067946NIGMS NIH HHS R01 GM081634NIGMS NIH HHS R01-GM081634-01NIGMS NIH HHS T32 GM007752
6 · The paper itself

Abstract

The pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) differentially attenuates Akt, PKC, and ERK1/2 signaling, thereby controlling the duration and amplitude of responses evoked by these kinases. PHLPP1 is expressed in the mammalian central clock, the suprachiasmatic nucleus, where it oscillates in a circadian fashion. To explore the role of PHLPP1 in vivo, we have generated mice with a targeted deletion of the PHLPP1 gene. Here we show that PHLPP1-null mice, although displaying normal circadian rhythmicity, have a drastically impaired capacity to stabilize the circadian period after light-induced resetting, producing a large phase shift after light resetting. Our findings reveal that PHLPP1 exerts a previously unappreciated role in circadian control, governing the consolidation of circadian periodicity after resetting.

Indexed as

LightAnimalsCircadian RhythmGene Expression RegulationMiceMice, KnockoutNuclear ProteinsPhosphoprotein Phosphatasestau ProteinsNuclear ProteinsPHLPP1 protein, mousePhosphoprotein Phosphatasestau Proteins

Identifiers

PMID20080691
PMCPMC2824391
OpenAlexW1993089729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.